613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

65.02

+0.99%↑

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

65.02

+0.99%↑

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

65.02

+0.99%↑

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

65.02

+0.99%↑

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

65.02

+0.99%↑

Начало・Списък с акции・Bayer AG

Bayer AG

Затворен

Сектор Финансови

28.935 -0.57

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

28.91

Максимум

29.185

Ключови измерители
By Trading Economics
Приходи	-2B -34M
Продажби	-2.6B 11B
P/E Средно за сектора	30.9 19.92
EPS	0.94
Марж на печалбата	-0.305
EBITDA	-2.6B 1.7B

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+3.52 upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	182M 28B
Предишно отваряне	29.51
Предишно затваряне	28.935

Настроения в новините

By Acuity

43%

57%

103 / 458 Класиране в Finance

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

27.69 / 28.975 Подкрепа & съпротива

Bayer AG Графика

Свързани новини

16.08.2024 г., 08:28 ч. UTC

Значими двигатели на пазара

Bayer Shares Surge After Appeal Win in Roundup Cancer Suit

15.08.2024 г., 21:43 ч. UTC

Печалби

Bayer's Monsanto Wins Appeal in Roundup Cancer Suit

6.08.2024 г., 10:56 ч. UTC

Печалби

Bayer Posts Net Loss as Tough Agriculture Market Bites -- Update

6.08.2024 г., 09:00 ч. UTC

Печалби

Correction to Bayer Article

6.08.2024 г., 06:29 ч. UTC

Печалби

Bayer Posts Net Loss, Dragged by Weaker Crop-Science Performance

14.05.2024 г., 13:21 ч. UTC

Печалби

Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update

14.05.2024 г., 06:13 ч. UTC

Печалби

Bayer Net Profit Falls on Lower Sales, Currency Headwinds

23.08.2024 г., 08:51 ч. UTC

Пазарно говорене

BMW's EV Coup Over Tesla in Europe Shows Strength as Tesla Products Age -- Market Talk

16.08.2024 г., 14:21 ч. UTC

Пазарно говорене

Bayer's Appeal Win Could Be First Step to End Roundup Litigation -- Market Talk

16.08.2024 г., 08:58 ч. UTC

Печалби

Горещи акции

Stocks to Watch Friday: Applied Materials, H&R Block, Bayer, Bavarian Nordic -- WSJ

6.08.2024 г., 10:47 ч. UTC

Пазарно говорене

Bayer Could Face Consensus Earnings Downgrades Amid Currency Headwinds -- Market Talk

6.08.2024 г., 08:55 ч. UTC

Пазарно говорене

Печалби

Bayer's 2Q Beat Boosted By Pharma Business -- Market Talk

6.08.2024 г., 08:20 ч. UTC

Пазарно говорене

Печалби

Bayer's 2Q Results Are a Mixed Bag -- Market Talk

6.08.2024 г., 06:57 ч. UTC

Пазарно говорене

Печалби

Bayer 2Q Results Could Lead to Muted Share Price Response -- Market Talk

6.08.2024 г., 05:34 ч. UTC

Печалби

Bayer Saw 2024 Core EPS Between EUR5.10 and EUR5.50

6.08.2024 г., 05:34 ч. UTC

Печалби

Bayer Saw 2024 Ebitda Before Special Between EUR10.7B and EUR11.3B

6.08.2024 г., 05:33 ч. UTC

Печалби

Bayer Backs 2024 View

6.08.2024 г., 05:33 ч. UTC

Печалби

Analysts Saw Bayer 2Q Ebitda Before Special Items at EUR2.08B

6.08.2024 г., 05:33 ч. UTC

Печалби

Bayer 2Q Ebitda Before Special Items EUR2.11B

6.08.2024 г., 05:32 ч. UTC

Печалби

Analysts Saw Bayer 2Q Net Pft at EUR70M

6.08.2024 г., 05:32 ч. UTC

Печалби

Bayer 2Q Net Loss EUR34M

6.08.2024 г., 05:31 ч. UTC

Печалби

Analysts Saw Bayer 2Q Core EPS at EUR0.84

6.08.2024 г., 05:31 ч. UTC

Печалби

Bayer 2Q Core EPS EUR0.94

6.08.2024 г., 05:31 ч. UTC

Печалби

Bayer 2Q EBIT EUR525M

6.08.2024 г., 05:30 ч. UTC

Печалби

Analysts Saw Bayer 2Q Rev at EUR10.82B

6.08.2024 г., 05:30 ч. UTC

Печалби

Bayer 2Q Rev EUR11.14B

12.07.2024 г., 07:05 ч. UTC

Пазарно говорене

Bayer's Cost-Savings and Cash Delivery Key Focus for 2Q -- Market Talk

5.06.2024 г., 09:57 ч. UTC

Горещи акции

Stocks to Watch Wednesday: CrowdStrike, HPE, Dollar Tree -- WSJ

14.05.2024 г., 11:00 ч. UTC

Пазарно говорене

Печалби

Bayer Earnings Show Progression on Turnaround Strategy -- Market Talk

14.05.2024 г., 05:34 ч. UTC

Печалби

Bayer Backs 2024 Currency-Adjusted Outlook

Сравнение с други в отрасъла

Ценова промяна

Bayer AG Прогноза

Ценова цел

By TipRanks

3.52% нагоре

12-месечна прогноза

Среден 30 EUR 3.52%

Висок 34 EUR

Нисък 26 EUR

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Bayer AG през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

10 ratings

Купи

Задържане

Продай

Според 10 анализатори, дали борсови рейтинги на Bayer AG през последните 3 месеца.

Техническа оценка

By Trading Central

27.69 / 28.975Подкрепа & съпротива

Recent bullish events outweigh bearish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Настроение

By Acuity

103 / 458 Класиране в Финансови

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non